The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Keep off the grass? Cannabis, cognition and addiction
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Adverse health effects of marijuana use.
Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1402309 · Cited by 2,774
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
Goldstein, R. Z., & Volkow, N. D. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3119 · Cited by 2,749
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Pertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Persistent cannabis users show neuropsychological decline from childhood to midlife
Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S. E., McDonald, K., Ward, A., Poulton, R., & Moffitt, T. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206820109 · Cited by 1,523
Is there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388
Drug addiction: updating actions to habits to compulsions ten years on
Everitt, B. J., & Robbins, T. W. (2016) · Annual Review of Psychology · doi:10.1146/annurev-psych-122414-033457 · Cited by 1,225
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H., & Astrup, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61721-8 · Cited by 1,097
Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013.
Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1858 · Cited by 1,086
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,080
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
The role of puberty in the developing adolescent brain
Blakemore, S., Burnett, S., & Dahl, R. E. (2010) · Human Brain Mapping · doi:10.1002/hbm.21052 · Cited by 1,011
ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.004 · Cited by 995
Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.6 · Cited by 771
Crean, R. D., Crane, N. A., & Mason, B. J. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31820c23fa · Cited by 732
Lopez-Quintero, C., Cobos, J. P. D. L., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., & Blanco, C. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.004 · Cited by 704
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
Neuropsychological Performance in Long-term Cannabis Users
Pope, H. G., Gruber, A. J., Hudson, J. I., Huestis, M. A., & Yurgelun-Todd, D. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.10.909 · Cited by 655
The dopamine theory of addiction: 40 years of highs and lows
Nutt, D. J., Lingford-Hughes, A., Erritzoe, D., & Stokes, P. R. A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3939 · Cited by 649
Escalation of Drug Use in Early-Onset Cannabis Users vs Co-twin Controls
Lynskey, M. T., Heath, A. C., Bucholz, K. K., Slutske, W. S., Madden, P. A. F., Nelson, E. C., Statham, D. J., & Martin, N. G. (2003) · JAMA · doi:10.1001/jama.289.4.427 · Cited by 649
Di Forti, M., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., Bianconi, F., Gardner-Sood, P., O'Connor, J., Russo, M., et al. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00117-5 · Cited by 588
Self-citationHirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.82 · Cited by 587
Hall, W. (2015) · Addiction · doi:10.1111/add.12703 · Cited by 579
The effects of adolescent cannabis use on educational attainment: a review
Lynskey, M., & Hall, W. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.951116213.x · Cited by 571
Cannabis Use and Earlier Onset of Psychosis: A Systematic Meta-analysis
Large, M., Sharma, S., Compton, M. T., Slade, T., & Nielssen, O. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.5 · Cited by 563
Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis
Carlezon, W. A., & Thomas, M. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.075 · Cited by 561
Sex differences in the adolescent brain
Lenroot, R. K., & Giedd, J. N. (2010) · Brain and Cognition · doi:10.1016/j.bandc.2009.10.008 · Cited by 556
Review of the Validity and Significance of Cannabis Withdrawal Syndrome
Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1967 · Cited by 522
The endocannabinoid system in guarding against fear, anxiety and stress
Lutz, B., Marsicano, G., Maldonado, R., & Hillard, C. J. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4036 · Cited by 506
Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499
Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis
Fergusson, D. M., Boden, J. M., & Horwood, L. J. (2006) · Addiction · doi:10.1111/j.1360-0443.2005.01322.x · Cited by 484
Endocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4004 · Cited by 481
Self-citationOpiate versus psychostimulant addiction: the differences do matter
Badiani, A., Belin, D., Epstein, D., Calu, D., & Shaham, Y. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3104 · Cited by 472
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Englund, A., Morrison, P. D., Nottage, J., Hague, D., Kane, F., Bonaccorso, S., Stone, J. M., Reichenberg, A., Brenneisen, R., Holt, D., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112460109 · Cited by 462
Young adult sequelae of adolescent cannabis use: an integrative analysis.
Silins, E., Horwood, L. J., Patton, G. C., Fergusson, D. M., Olsson, C. A., Hutchinson, D. M., Spry, E., Toumbourou, J. W., Degenhardt, L., Swift, W., et al. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70307-4 · Cited by 443
Elevated endogenous cannabinoids in schizophrenia
Leweke, F. M., Giuffrida, A., Wurster, U., Emrich, H. M., & Piomelli, D. (1999) · NeuroReport · doi:10.1097/00001756-199906030-00008 · Cited by 432
Batalla, A., Bhattacharyya, S., Yücel, M., Fusar-Poli, P., Crippa, J. A., Nogué, S., Torrens, M., Pujol, J., Farré, M., & Martin-Santos, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055821 · Cited by 416
A Systematic Review of the Relationship between High School Dropout and Substance Use
Townsend, L., Flisher, A. J., & King, G. (2007) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-007-0023-7 · Cited by 409
Nissen, S. E., Nicholls, S. J., Wolski, K., Rodés-Cabau, J., Cannon, C. P., Deanfield, J. E., Després, J.-P., Kastelein, J. J. P., Steinhubl, S. R., Kapadia, S., et al. (2008) · JAMA · doi:10.1001/jama.299.13.1547 · Cited by 403
Early phytocannabinoid chemistry to endocannabinoids and beyond
Mechoulam, R., Hanuš, L. O., Pertwee, R., & Howlett, A. C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3811 · Cited by 393
Specific attentional dysfunction in adults following early start of cannabis use
Ehrenreich, H., Kunert, H. J., Moeller, M. R., Poser, W., Schilling, L., Gigerenzer, G., Hoehe, M. R., & Rinn, T. (1999) · Psychopharmacology · doi:10.1007/s002130050892 · Cited by 387
Curran, V., Brignell, C., Fletcher, S., Middleton, P., & Henry, J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1169-0 · Cited by 369
Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1Areceptors
Zanelati, T., Biojone, C., Moreira, F., Guimarães, F., & Joca, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00521.x · Cited by 366
Egertov�, M., & Elphick, M. R. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000626)422:2<159::aid-cne1>3.0.co;2-1 · Cited by 364
Stages and Pathways of Drug Involvement: Examining The Gateway Hypothesis
Kandel, D. B. (2002) · Cited by 363
Cannabis and adolescent brain development.
Lubman, D. I., Cheetham, A., & Yücel, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.009 · Cited by 360
Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence
Patton, G. C., Coffey, C., Carlin, J. B., Sawyer, S. M., & Lynskey, M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01220.x · Cited by 356
Rubino, T., Vigano', D., Realini, N., Guidali, C., Braida, D., Capurro, V., Castiglioni, C., Cherubino, F., Romualdi, P., Candeletti, S., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301664 · Cited by 345
Cannabinoids Enhance Subsecond Dopamine Release in the Nucleus Accumbens of Awake Rats
Cheer, J. F., Wassum, K. M., Heien, M. L. A. V., Phillips, P. E. M., & Wightman, R. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0529-04.2004 · Cited by 343
Effects of Schedule I drug laws on neuroscience research and treatment innovation
Nutt, D. J., King, L. A., & Nichols, D. E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3530 · Cited by 337
Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis
(2002) · Cambridge University Press eBooks · doi:10.1017/cbo9780511499777 · Cited by 336
Winstock, A. R., & Barratt, M. J. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.12.011 · Cited by 331
Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning
Mulder, J., Aguado, T., Keimpema, E., Barabás, K., Ballester Rosado, C. J., Nguyen, L., Monory, K., Marsicano, G., Di Marzo, V., Hurd, Y. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803545105 · Cited by 327
Crane, N. A., Schuster, R. M., Fusar-Poli, P., & Gonzalez, R. (2013) · Neuropsychology Review · doi:10.1007/s11065-012-9222-1 · Cited by 309
Freeman, T. P., & Winstock, A. R. (2015) · Psychological Medicine · doi:10.1017/s0033291715001178 · Cited by 308
Self-citationA Double-Blind Randomized Controlled Trial of N -Acetylcysteine in Cannabis-Dependent Adolescents
Gray, K. M., Carpenter, M. J., Baker, N. L., DeSantis, S. M., Kryway, E., Hartwell, K. J., McRae-Clark, A. L., & Brady, K. T. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010055 · Cited by 306
Morgan, C. J. A., Schafer, G., Freeman, T. P., & Curran, H. V. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.077503 · Cited by 305
Cannabis and educational achievement
Fergusson, D. M., Horwood, L. J., & Beautrais, A. L. (2003) · Addiction · doi:10.1111/j.1360-0443.2003.00573.x · Cited by 302
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Morgan, C. J. A., & Curran, H. V. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046649 · Cited by 300
Self-citationBerghuis, P., Dobszay, M. B., Wang, X., Spano, S., Ledda, F., Sousa, K. M., Schulte, G., Ernfors, P., Mackie, K., Paratcha, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509494102 · Cited by 291
Quinn, H. R., Matsumoto, I., Callaghan, P. D., Long, L. E., Arnold, J. C., Gunasekaran, N., Thompson, M. R., Dawson, B., Mallet, P. E., Kashem, M. A., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301475 · Cited by 290
Schreiner, A. M., & Dunn, M. E. (2012) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0029117 · Cited by 289
Ellgren, M., Spano, S. M., & Hurd, Y. L. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301127 · Cited by 287
Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., Vogt, L. J., & Sim‐Selley, L. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732447.x · Cited by 273
Regulation of Cannabinoid CB1 Receptors in the Central Nervous System by Chronic Cannabinoids
Sim-Selley, L. J. (2003) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v15.i2.10 · Cited by 271
Testing hypotheses about the relationship between cannabis use and psychosis
Degenhardt, L., Hall, W., & Lynskey, M. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00064-4 · Cited by 270
Age of onset of marijuana use and executive function.
Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Racine, M., & Lukas, S. E. (2012) · Psychology of Addictive Behaviors · doi:10.1037/a0026269 · Cited by 267
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial
Allsop, D. J., Copeland, J., Lintzeris, N., Dunlop, A. J., Montebello, M., Sadler, C., Rivas, G. R., Holland, R. M., Muhleisen, P., Norberg, M. M., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3947 · Cited by 266
D'Souza, D. C., Ranganathan, M., Braley, G., Gueorguieva, R., Zimolo, Z., Cooper, T., Perry, E., & Krystal, J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301643 · Cited by 262
Chen, C.-Y., O’Brien, M. S., & Anthony, J. C. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.014 · Cited by 260
Effects of Cannabis on the Adolescent Brain
Jacobus, J., & Tapert, S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990426 · Cited by 259
Verweij, K. J. H., Zietsch, B. P., Lynskey, M. T., Medland, S. E., Neale, M. C., Martin, N. G., Boomsma, D. I., & Vink, J. M. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02831.x · Cited by 258
Yucel, M., Bora, E., Lubman, D. I., Solowij, N., Brewer, W. J., Cotton, S. M., Conus, P., Takagi, M. J., Fornito, A., Wood, S. J., et al. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq079 · Cited by 255
Corticotropin releasing factor: A key role in the neurobiology of addiction
Zorrilla, E. P., Logrip, M. L., & Koob, G. F. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.001 · Cited by 254
Neurocognitive consequences of marihuana—a comparison with pre-drug performance
Fried, P. A., Watkinson, B., & Gray, R. (2005) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.11.003 · Cited by 253
Carr, A. J., Cooper, C. D., Campbell, M. K., Rees, J. L., Moser, J., Beard, D. J., Fitzpatrick, R., Gray, A., Dawson, J., Murphy, J., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19800 · Cited by 248
Mason, B. J., Crean, R., Goodell, V., Light, J. M., Quello, S., Shadan, F., Buffkins, K., Kyle, M., Adusumalli, M., Begovic, A., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.14 · Cited by 242
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
Di Forti, M., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli, A., Sirianni, M., La Cascia, C., Stilo, S. A., Marques, T. R., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.020 · Cited by 234
Self-citationLevin, F. R., Mariani, J. J., Brooks, D. J., Pavlicova, M., Cheng, W., & Nunes, E. V. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.12.010 · Cited by 232
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling
Dudok, B., Barna, L., Ledri, M., Szabó, S. I., Szabadits, E., Pintér, B., Woodhams, S. G., Henstridge, C. M., Balla, G. Y., Nyilas, R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3892 · Cited by 227
Pistis, M., Ferraro, L., Pira, L., Flore, G., Tanganelli, S., Gessa, G. L., & Devoto, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03055-x · Cited by 227
Self-administration of ?9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys
Justinova, Z., Tanda, G., Redhi, G. H., & Goldberg, S. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1484-0 · Cited by 220
(2014) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199662685.001.0001 · Cited by 219
A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity
Mato, S., Chevaleyre, V., Robbe, D., Pazos, A., Castillo, P. E., & Manzoni, O. J. (2004) · Nature Neuroscience · doi:10.1038/nn1251 · Cited by 218
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Bloomfield, M. A. P., Morgan, C. J. A., Egerton, A., Kapur, S., Curran, H. V., & Howes, O. D. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.027 · Cited by 215
Self-citationHaney, M., Malcolm, R. J., Babalonis, S., Nuzzo, P. A., Cooper, Z. D., Bedi, G., Gray, K. M., McRae-Clark, A., Lofwall, M. R., Sparenborg, S., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.367 · Cited by 206
Allsop, D. J., Norberg, M. M., Copeland, J., Fu, S., & Budney, A. J. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.06.003 · Cited by 205
Facilitation of brain stimulation reward byΔ 9-tetrahydrocannabinol
Gardner, E. L., Paredes, W., Smith, D., Donner, A., Milling, C., Cohen, D., & Morrison, D. (1988) · Psychopharmacology · doi:10.1007/bf02431546 · Cited by 204
D’Souza, D. C., Cortes-Briones, J. A., Ranganathan, M., Thurnauer, H., Creatura, G., Surti, T., Planeta, B., Neumeister, A., Pittman, B., Normandin, M. D., et al. (2016) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.09.008 · Cited by 204
Szutorisz, H., DiNieri, J. A., Sweet, E., Egervari, G., Michaelides, M., Carter, J. M., Ren, Y., Miller, M. L., Blitzer, R. D., & Hurd, Y. L. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.352 · Cited by 197
Morgan, C. J., Freeman, T. P., Schafer, G. L., & Curran, H. V. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.58 · Cited by 196
Self-citationMorgan, C. J. A., Gardener, C., Schafer, G., Swan, S., Demarchi, C., Freeman, T. P., Warrington, P., Rupasinghe, I., Ramoutar, A., Tan, N., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711001322 · Cited by 195
Hoffman, A. F., & Lupica, C. R. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.1.72 · Cited by 194
Hoffman, A. F., Oz, M., Caulder, T., & Lupica, C. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04815.2003 · Cited by 193
Mesolimbic dopaminergic decline after cannabinoid withdrawal
Diana, M., Melis, M., Muntoni, A. L., & Gessa, G. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10269 · Cited by 192
Cannabidiol enhances consolidation of explicit fear extinction in humans
Das, R. K., Kamboj, S. K., Ramadas, M., Yogan, K., Gupta, V., Redman, E., Curran, H. V., & Morgan, C. J. A. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2955-y · Cited by 191
Self-citationThe clinical relevance of attentional bias in substance use disorders
Field, M., Marhe, R., & Franken, I. H. A. (2014) · CNS Spectrums · doi:10.1017/s1092852913000321 · Cited by 190
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats
Fattore, L., Cossu, G., Martellotta, C., & Fratta, W. (2001) · Psychopharmacology · doi:10.1007/s002130100734 · Cited by 187
Hindocha, C., Freeman, T. P., Schafer, G., Gardener, C., Das, R. K., Morgan, C. J. A., & Curran, H. V. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.014 · Cited by 183
Self-citationVandrey, R. G., Budney, A. J., Hughes, J. R., & Liguori, A. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.06.010 · Cited by 182
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
Swift, W., Wong, A., Li, K. M., Arnold, J. C., & McGregor, I. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070052 · Cited by 182
Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms
Budney, A. J., Vandrey, R. G., Hughes, J. R., Moore, B. A., & Bahrenburg, B. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.04.014 · Cited by 180
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 180
Self-citationvan der Pol, P., Liebregts, N., de Graaf, R., Korf, D. J., van den Brink, W., & van Laar, M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.06.009 · Cited by 180
Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies
Jackson, N. J., Isen, J. D., Khoddam, R., Irons, D., Tuvblad, C., Iacono, W. G., McGue, M., Raine, A., & Baker, L. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516648113 · Cited by 178
Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
Koethe, D., Giuffrida, A., Schreiber, D., Hellmich, M., Schultze-Lutter, F., Ruhrmann, S., Klosterkötter, J., Piomelli, D., & Leweke, F. M. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.053843 · Cited by 177
Two brain sites for cannabinoid reward
Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S. R., & Wise, R. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3554-05.2006 · Cited by 174
Valverde, O., Noble, F., Beslot, F., Daugé, V., Fournié‐Zaluski, M., & Roques, B. P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01558.x · Cited by 173
Cheetham, A., Allen, N. B., Whittle, S., Simmons, J. G., Yücel, M., & Lubman, D. I. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.029 · Cited by 170
Evaluating alternative cannabis regimes
MacCoun, R., & Reuter, P. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.123 · Cited by 168
Di Marzo, V., Berrendero, F., Bisogno, T., González, S., Cavaliere, P., Romero, J., Cebeira, M., Ramos, J. A., & Fernández‐Ruiz, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741627.x · Cited by 168
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users
Ramaekers, J. G., Theunissen, E. L., de Brouwer, M., Toennes, S. W., Moeller, M. R., & Kauert, G. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2042-1 · Cited by 164
Coffey, C., Carlin, J. B., Lynskey, M. T., Li, N., & Patton, G. C. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.182.4.330 · Cited by 162
Hippocampal harms, protection and recovery following regular cannabis use
Yücel, M., Lorenzetti, V., Suo, C., Zalesky, A., Fornito, A., Takagi, M., Lubman, D. I., & Solowij, N. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.201 · Cited by 162
Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain
Wang, X., Dow-Edwards, D. L., Keller, É., & Hurd, Y. L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00020-4 · Cited by 159
Jentsch, J. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00018-3 · Cited by 158
Pharmacotherapies for cannabis dependence.
Marshall, K., Gowing, L., Ali, R., & Le Foll, B. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub2 · Cited by 156
CB1 receptor-deficient mice as a model for depression
Valverde, O., & Torrens, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.031 · Cited by 156
Differential effects of delta9-THC on learning in adolescent and adult rats
Cha, Y. M., White, A. M., Kuhn, C. M., Wilson, W. A., & Swartzwelder, H. S. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.03.006 · Cited by 155
Braida, D., Iosuè, S., Pegorini, S., & Sala, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.043 · Cited by 154
Behavioral Neurobiology of Anxiety and Its Treatment
Stein, M. B., & Steckler, T. (2010) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-02912-7 · Cited by 154
Tzavara, E. T., Wade, M. R., & Nomikos, G. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09374.2003 · Cited by 153
Endogenous cannabinoids as an aversive or counter-rewarding system in the rat
Sañudo-Peña, M. C., Tsou, K., Delay, E. R., Hohman, A. G., Force, M., & Walker, J. M. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13424-3 · Cited by 152
Cannabinoid receptors and reward in the rat: a conditioned place preference study
Cheer, J. F., Kendall, D. A., & Marsden, C. A. (2000) · Psychopharmacology · doi:10.1007/s002130000481 · Cited by 151
[18 F ] MK ‐9470 PET measurement of cannabinoid CB 1 receptor availability in chronic cannabis users
Ceccarini, J., Kuepper, R., Kemels, D., van Os, J., Henquet, C., & Laere, K. V. (2013) · Addiction Biology · doi:10.1111/adb.12116 · Cited by 149
Freeman, T. P., Morgan, C. J. A., Hindocha, C., Schäfer, G., Das, R., & Curran, H. V. (2014) · Addiction · doi:10.1111/add.12634 · Cited by 149
Self-citationJager, G., Block, R. I., Luijten, M., & Ramsey, N. F. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.02.001 · Cited by 147
Bossong, M. G., Mehta, M. A., van Berckel, B. N. M., Howes, O. D., Kahn, R. S., & Stokes, P. R. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3915-0 · Cited by 146
The Endocannabinoid Signaling System in the CNS
Hillard, C. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.001 · Cited by 144
Metabolic Effects of Chronic Cannabis Smoking
Muniyappa, R., Sable, S., Ouwerkerk, R., Mari, A., Gharib, A. M., Walter, M. F., Courville, A. B., Hall, G., Chen, K. Y., Volkow, N. D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2303 · Cited by 140
Uhl, G. R., Drgon, T., Johnson, C., Fatusin, O. O., Liu, Q., Contoreggi, C. S., Li, C., Buck, K. J., & Crabbe, J. C. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.042 · Cited by 138
Tomasiewicz, H. C., Jacobs, M. M., Wilkinson, M. B., Wilson, S. P., Nestler, E. J., & Hurd, Y. L. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.026 · Cited by 138
Gonzalez, R., Schuster, R. M., Mermelstein, R. J., Vassileva, J., Martin, E. M., & Diviak, K. R. (2012) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2012.703642 · Cited by 137
Self-administration of cannabinoids by experimental animals and human marijuana smokers
Justinová, Z., Goldberg, S. R., Heishman, S. J., & Tanda, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.026 · Cited by 137
Cannabinoids Inhibit the Formation of New Synapses between Hippocampal Neurons in Culture
Kim, D., & Thayer, S. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-10-j0004.2001 · Cited by 134
Daily Marijuana Use Is Not Associated with Brain Morphometric Measures in Adolescents or Adults
Weiland, B., Thayer, R., Depue, B., Sabbineni, A., Bryan, A., & Hutchison, K. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2946-14.2015 · Cited by 132
Candidate genes for cannabis use disorders: findings, challenges and directions.
Agrawal, A., & Lynskey, M. T. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02504.x · Cited by 128
van der Pol, P., Liebregts, N., Brunt, T. M., van Amsterdam, J., de Graaf, R., Korf, D. J., van den Brink, W., & van Laar, M. (2014) · Addiction · doi:10.1111/add.12508 · Cited by 123
Marijuana use and high school dropout: the influence of unobservables
McCaffrey, D. F., Pacula, R. L., Han, B., & Ellickson, P. L. (2009) · Health Economics · doi:10.1002/hec.1561 · Cited by 123
Hindocha, C., Shaban, N. D. C., Freeman, T. P., Das, R., Gale, G., Schäfer, G., Falconer, C. J., Morgan, C. J. A., & Curran, H. V. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.004 · Cited by 121
Self-citationSchlosburg, J. E., Carlson, B. L. A., Ramesh, D., Abdullah, R. A., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9110-7 · Cited by 121
Sim‐Selley, L. J., Schechter, N. S., Rorrer, W. K., Dalton, G. D., Hernandez, J., Martin, B. R., & Selley, D. E. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019612 · Cited by 120
Braida, D., Pozzi, M., Parolaro, D., & Sala, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00766-x · Cited by 118
Tanda, G., Munzar, P., Goldberg, S. R., & Justinova, Z. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1693-6 · Cited by 111
Adolescent cannabis and tobacco use and educational outcomes at age 16: birth cohort study
Stiby, A. I., Hickman, M., Munafo, M. R., Heron, J., Yip, V., & Macleod, J. (2014) · Addiction · doi:10.1111/add.12827 · Cited by 110
The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study
Bloomfield, M., Morgan, C. J. A., Kapur, S., Curran, H. V., & Howes, O. D. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3523-4 · Cited by 106
Self-citationCerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms
Morgan, C. J. A., Page, E., Schaefer, C., Chatten, K., Manocha, A., Gulati, S., Curran, H. V., Brandner, B., & Leweke, F. M. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.121178 · Cited by 106
Self-citationMokrysz, C., Landy, R., Gage, S., Munafo, M. R., Roiser, J. P., & Curran, H. V. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115622241 · Cited by 104
Self-citationMorgan, C. J. A., Freeman, T. P., Powell, J. F., & Curran, H. V. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.219 · Cited by 104
Self-citationPrior Exposure to THC Increases the Addictive Effects of Nicotine in Rats
Panlilio, L. V., Zanettini, C., Barnes, C., Solinas, M., & Goldberg, S. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.16 · Cited by 103
Verweij, K. J. H., Huizink, A. C., Arpana Agrawal, A., Martin, N. G., & Lynskey, M. T. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.07.034 · Cited by 101
Lorenzetti, V., Solowij, N., Fornito, A., Lubman, D. I., & Yücel, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990435 · Cited by 101
van der Pol, P., Liebregts, N., de Graaf, R., ten Have, M., Korf, D. J., van den Brink, W., & van Laar, M. (2013) · Addiction · doi:10.1111/add.12196 · Cited by 99
Niesink, R. J. M., Rigter, S., Koeter, M. W. J., & Brunt, T. M. (2015) · Addiction · doi:10.1111/add.13082 · Cited by 98
Chen, J., Marmur, R., Pulles, A., Paredes, W. M., & Gardner, E. L. (1993) · Brain Research · doi:10.1016/0006-8993(93)90298-2 · Cited by 94
AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder
the Genetic Risk and Outcome of Psychosis (GROUP) Investigators, van Winkel, R., Genetic Risk and Outcome of Psychosis (GROUP) Investigators, van Beveren, N. J. M., & Simons, C. J. P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.141 · Cited by 94
The endocannabinoid system as a target for the treatment of cannabis dependence
Clapper, J. R., Mangieri, R. A., & Piomelli, D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.018 · Cited by 94
Manzanares, J., Corchero, J., Romero, J., Fernández‐Ruíz, J., Ramos, J. A., & Fuentes, J. A. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00371-9 · Cited by 93
Effects of Δ9-Tetrahydrocannabinol on Human Working Memory Function
Bossong, M. G., Jansma, J. M., van Hell, H. H., Jager, G., Oudman, E., Saliasi, E., Kahn, R. S., & Ramsey, N. F. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.008 · Cited by 93
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92
Self-citationHiguera‐Matas, A., Soto‐Montenegro, M. L., Olmo, N. D., Miguéns, M., Torres, I., Vaquero, J. J., Sánchez, J. C., García-Lecumberri, C., Desco, M., & Ambrosio, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301467 · Cited by 92
Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review
Batalla, A., Crippa, J. A., Busatto, G. F., Guimaraes, F. S., Zuardi, A. W., Valverde, O., Atakan, Z., McGuire, P. K., Bhattacharyya, S., & Martín-Santos, R. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990432 · Cited by 91
Dependence of mesolimbic dopamine transmission on Δ9-tetrahydrocannabinol
Tanda, G., Loddo, P., & Chiara, G. D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00384-2 · Cited by 89
Grant, J. D., Scherrer, J. F., Lynskey, M. T., Arpana Agrawal, A., Duncan, A. E., Haber, J. R., Heath, A. C., & Bucholz, K. K. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01752.x · Cited by 89
Pistis, M., Muntoni, A. L., Pillolla, G., & Gessa, G. L. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02019.x · Cited by 88
Solinas, M., Panlilio, L. V., & Goldberg, S. R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300431 · Cited by 88
Lecca, D., Cacciapaglia, F., Valentini, V., & Chiara, G. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0475-3 · Cited by 84
Temple, E. C., Brown, R. F., & Hine, D. W. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03139.x · Cited by 81
Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders
Carvalho, A. F., & Bockstaele, E. J. V. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.01.008 · Cited by 77
The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia
Volk, D. W., & Lewis, D. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.015 · Cited by 74
Self-citationSCHNEIDER, M., & Koch, M. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.009 · Cited by 74
Haney, M., Ramesh, D., Glass, A., Pavlicova, M., Bedi, G., & Cooper, Z. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.108 · Cited by 73
Hooper, S. R., Woolley, D. P., & Bellis, M. D. D. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3463-z · Cited by 73
Pharmacological Treatment of Cannabis Dependence
Weinstein, A. M., & Gorelick, D. A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796150846 · Cited by 72
Vlachou, S., Nomikos, G. G., Stephens, D., & Panagis, G. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282186cf2 · Cited by 72
Panlilio, L. V., Solinas, M., Matthews, S. A., & Goldberg, S. R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301109 · Cited by 68
Kucewicz, M. T., Tricklebank, M. D., Bogacz, R., & Jones, M. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2970-11.2011 · Cited by 67
González, S. R., Fernández‐Ruíz, J., Marzo, V. D., Hernández, M., Arévalo, C., Nicanor, C., Cascio, M. G., Ambrosio, E., & Ramos, J. A. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.12.011 · Cited by 66
CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat
Vlachou, S., Nomikos, G. G., & Panagis, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2050-0 · Cited by 66
Cooper, K. L., Chatters, R., Kaltenthaler, E., & Wong, R. (2015) · Health Technology Assessment · doi:10.3310/hta19560 · Cited by 65
Cadoni, C., Simola, N., Espa, E., Fenu, S., & Chiara, G. D. (2013) · Addiction Biology · doi:10.1111/adb.12085 · Cited by 64
Flórez‐Salamanca, L., Secades‐Villa, R., Budney, A. J., García–Rodríguez, O., Wang, S., & Blanco, C. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.01.013 · Cited by 61
Investigating the interaction between schizotypy, divergent thinking and cannabis use
Schäfer, G., Feilding, A., Morgan, C. J. A., Agathangelou, M., Freeman, T. P., & Curran, H. V. (2012) · Consciousness and Cognition · doi:10.1016/j.concog.2011.11.009 · Cited by 59
Self-citationLocal administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex
Page, M. E., Oropeza, V. C., & Bockstaele, E. J. V. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.009 · Cited by 58
Verrico, C. D., Gu, H., Peterson, M. L., Sampson, A. R., & Lewis, D. A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030335 · Cited by 56
Self-citationBuckner, J. D., & Carroll, K. M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.10.010 · Cited by 55
Hines, L. A., Morley, K. I., Strang, J., Arpana Agrawal, A., Nelson, E. C., Statham, D. J., Martin, N. G., & Lynskey, M. T. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.12.032 · Cited by 52
Crane, N. A., Schuster, R. M., Mermelstein, R. J., & González, R. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1020770 · Cited by 51
Moranta, D., Esteban, S., & García-Sevilla, J. A. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0337-0 · Cited by 47
Cited by
Cannabis use and cannabis use disorder
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00247-4 · Cited by 552
New trends in cannabis potency in USA and Europe during the last decade (2008–2017)
Chandra, S., Radwan, M. M., Majumdar, C. G., Church, J. C., Freeman, T. P., & ElSohly, M. A. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00983-5 · Cited by 469
Self-citationWise, R. A., & Robble, M. A. (2020) · Annual Review of Psychology · doi:10.1146/annurev-psych-010418-103337 · Cited by 404
Freeman, T. P., Craft, S., Wilson, J., Stylianou, S., ElSohly, M., Di Forti, M., & Lynskey, M. T. (2021) · Addiction · doi:10.1111/add.15253 · Cited by 337
Self-citationCannabis and mental illness: a review
Lowe, D. J. E., Sasiadek, J. D., Coles, A. S., & George, T. P. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0970-7 · Cited by 253
Metadata
- Authors
- Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H.
- Venue
- Nature Reviews Neuroscience
- Published
- 2016-04-07
- Volume
- 17
- Issue
- 5
- Pages
- 293-306
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2315745933
- Cited by
- 389
- References
- 216
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.